177 related articles for article (PubMed ID: 27067283)
1. New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii.
Smani Y; Pachón-Ibáñez ME; Pachón J
Expert Opin Pharmacother; 2016 Jun; 17(9):1207-14. PubMed ID: 27067283
[TBL] [Abstract][Full Text] [Related]
2. Use of adjuvants in the treatment of Acinetobacter baumannii.
Pachón-Ibáñez ME; Smani Y; Pachón J
Expert Rev Anti Infect Ther; 2016; 14(2):153-5. PubMed ID: 26620637
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Evaluation of Antimicrobial Peptide Tridecaptin M in Combination with Other Antibiotics against Multidrug Resistant
Jangra M; Raka V; Nandanwar H
Molecules; 2020 Jul; 25(14):. PubMed ID: 32708842
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.
Durante-Mangoni E; Utili R; Zarrilli R
Future Microbiol; 2014; 9(6):773-89. PubMed ID: 25046524
[TBL] [Abstract][Full Text] [Related]
5. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
6. Treatment options for multidrug-resistant nonfermenters.
Briceño DF; Quinn JP; Villegas MV
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR)
Xiong YQ; Li L; Zhou Y; Kraus CN
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382389
[No Abstract] [Full Text] [Related]
8. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.
Shin B; Park W
J Microbiol; 2017 Nov; 55(11):837-849. PubMed ID: 29076065
[TBL] [Abstract][Full Text] [Related]
10. Treatment of multiresistant Acinetobacter baumannii infections.
Pachón J; Vila J
Curr Opin Investig Drugs; 2009 Feb; 10(2):150-6. PubMed ID: 19197792
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
Saçar S; Turgut H; Cenger DH; Coşkun E; Asan A; Kaleli I
J Infect Dev Ctries; 2007 Dec; 1(3):342-4. PubMed ID: 19734617
[TBL] [Abstract][Full Text] [Related]
12. Emergence of antimicrobial resistance among Acinetobacter species: a global threat.
Clark NM; Zhanel GG; Lynch JP
Curr Opin Crit Care; 2016 Oct; 22(5):491-9. PubMed ID: 27552304
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
14. Role of combination antibiogram in empirical treatment of infection due to multidrug-resistant Acinetobacter baumannii.
Apisarnthanarak A; Mundy LM
Infect Control Hosp Epidemiol; 2008 Jul; 29(7):678-9. PubMed ID: 18624670
[No Abstract] [Full Text] [Related]
15. Therapeutic options for Acinetobacter baumannii infections: an update.
Vila J; Pachón J
Expert Opin Pharmacother; 2012 Nov; 13(16):2319-36. PubMed ID: 23035697
[TBL] [Abstract][Full Text] [Related]
16. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
Maragakis LL; Perl TM
Clin Infect Dis; 2008 Apr; 46(8):1254-63. PubMed ID: 18444865
[TBL] [Abstract][Full Text] [Related]
17. Infections Due to Acinetobacter baumannii in the ICU: Treatment Options.
Lynch JP; Zhanel GG; Clark NM
Semin Respir Crit Care Med; 2017 Jun; 38(3):311-325. PubMed ID: 28578555
[TBL] [Abstract][Full Text] [Related]
18. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
[TBL] [Abstract][Full Text] [Related]
19. Confronting multidrug-resistant Acinetobacter baumannii: a review.
Neonakis IK; Spandidos DA; Petinaki E
Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
[TBL] [Abstract][Full Text] [Related]
20. Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.
Phee LM; Betts JW; Bharathan B; Wareham DW
Antimicrob Agents Chemother; 2015 Aug; 59(8):4544-50. PubMed ID: 25987639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
